As earnings reports continue to roll in, investors may be taking a closer look at companies that they own. Staying on top of the most recent releases may help investors figure out if the company is well-positioned for future success. Taking a look at some earnings projections, we note that the current quarter EPS consensus estimate for Haemonetics Corporation (NYSE:HAE) is 0.44. This EPS estimate consists of 5 sell-side analysts taken into consideration by Zacks Research. For the last reporting period, the company reported a quarterly EPS of 0.48. Sell-side analysts often provide their best researched estimates for what the company will report. These estimates carry a lot of weight on Wall Street and the investing community. When a company reports actual earnings results, the surprise factor may cause the stock price to fluctuate more than normal. Investors will often pay added attention to a company that has surpassed expectations by a wide margin.
Investors may have to periodically remind themselves that they don’t have to be locked in to any given trade. Sometimes, even the best researched trade may go sour. Doubling down on losses can be a dangerous game even for the experienced investor. Investors may hold out exiting a certain trade with the hope that eventually the stock will bounce back and they can at least break even. Of course this may occasionally be the case, but there is also the chance that a stock may continue to spiral downward. Investors who are able to control their emotions and logically manage their positions may give themselves a slight advantage when tough decisions need to be made. Nobody can say for sure which way the market momentum will swing on any given day, but being prepared for those swings can help the trader or investor make the best possible decisions at any given moment.
Wall Street analysts often give buy/sell/hold ratings for the companies that they track. Investors have the ability to view these sell-side ratings in order to help with their own stock research. Analyst ratings may have different interpretations. According to analysts polled by Zacks Research, the current average broker rating on shares of Haemonetics Corporation (NYSE:HAE) is 2.43. This rating uses a scale between 1 and 5. Following this scale, a rating of 1 would represent a Strong Buy, and a rating of 5 would indicate a Strong Sell recommendation. Out of all these analysts offering ratings, 3 have rated the stock a Strong Buy or Buy, according to Zacks Research.
Shifting the focus to some possible support and resistance levels on shares of Haemonetics Corporation (NYSE:HAE), we note that the 52-week high is currently $58.99, and the 52-week low is currently $36.9. When shares are trading near to the 52-week high or 52-week low, investors may be watching for a break through either level. Investors may also be watching historical price action. Over the past 12 weeks, the stock has moved 35.25%. Going back to the start of the year, we can see that shares have moved 45.85%. Over the last 4 weeks, shares have seen a change of 23.28%. Over the last 5 trading days, the stock has moved -0.61%. Checking in on recent session activity, we have seen that the stock has been trading near the $58.63 mark.
Looking further at shares of Haemonetics Corporation (NYSE:HAE), we have noticed that the current consensus target price is $54.25. Wall Street analysts have the ability to create price target estimates for where they think the stock will be moving in the near-term. Because price target projections can differ from one analyst to the next, they may span a wide range of values. Many investors will closely track target prices, and they tend to pay extra close attention when analysts make revisions to those targets.
Many traders use technical analysis to make stock trading decisions. One of the most popular technical indicators is the moving average. Moving averages are versatile and can be used to smooth out stock price fluctuations. Moving averages can be used to help determine underlying trends and to spot early stage directional changes. Moving averages can be observed from various time periods. Depending on the time frame used when monitoring moving averages, investors may look to identify buy and sell signals based on stock price crossovers of a particular MA. Many traders will use MA indicators alongside other technical indicators to help spot the best positions for entry and exit points.